SIMILARITY OF TWINS TO SINGLETON MATERNAL SERUM ALPHA-FETOPROTEIN RATIO BY RACE - NO NEED TO ESTABLISH SPECIFIC MULTIFETAL TABLES

被引：5

作者：

DRUGAN, A ^{[1
]}

OBRIEN, JE ^{[1
]}

GAMBINO, R ^{[1
]}

JOHNSON, MP ^{[1
]}

EVANS, MI ^{[1
]}

机构：

[1] WAYNE STATE UNIV,HUTZEL HOSP,DEPT OBSTET & GYNECOL,DIV REPROD GENET,DETROIT,MI 48201

来源：

FETAL DIAGNOSIS AND THERAPY | 1993年 / 8卷 / 02期

关键词：

MATERNAL SERUM ALPHA-FETOPROTEIN; PRENATAL DIAGNOSIS; TWINS;

D O I：

10.1159/000263753

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

The purpose of this study was to assess. the need for race-specific maternal serum a-fetoprotein (MSAFP) curves in twin gestations. MSAFP values were evaluated in 535 samples obtained from twin gestations. Results were grouped according to gestational age (from 15 to 20 weeks), as with our singletons. Separate median curves were determined for black and for white pregnancies. On average, the median serum alpha-fetoprotein (AFP) for twins was about twice (2.1 +/- 0.3) the median of singletons. MSAFP in blacks was commonly higher than in white pregnancies of comparable gestational age. Using a 4.5 multiple of the singleton median cutoff in twin white pregnancies, 3.9 % of the results were defined as 'high', similar to the rate observed in singleton pregnancies. 'Low' results in twins were defined as AFP values lower than 1.0 multiples of the singleton median (in pregnancies of similar gestational age and race). About 7 % of the serum samples for whites were defined as 'low' by this criteria. Data for blacks were comparable. Race-dependent median values should be used for MSAFP interpretation in twin as well as singleton pregnancies. 'High' and 'low' percentages are comparable to our large data bank of singleton pregnancies and seem to be adequate for interpretation of serum AFP in twins. Therefore, the race-specific singleton multiples are sufficient, obviating the need to build specific median curves for multifetal gestations.

引用

页码：84 / 88

页数：5

共 11 条

[1]

Professional Liability Implications of AFP Testing, American College of Obstetricians and Gynecologists, (1985)

[2]

Milunsky A., Jick J.S., Bruel C.L., Predictive values, relative risks and overall benefits of high and low maternal serum alpha-fctoprotein screening in singleton pregnancies: New epidemiologic data, Am J Obset Gynecol, 161, pp. 291-297, (1989)

[3]

Schell D.A., Drugan A., Brindley B.A., Combined ultrasonography and amniocentesis for pregnant women with elevated scrum alpha-fetoprotcin. Revising the risk estimate, J Reprod Med, 35, pp. 543-546, (1990)

[4]

Nelson L.H., Bensen J.K., Burton B.K., Outcomes in patients with unusually high maternal scrum alpha-feto-protein levels, Am J Obslet Gynecol, 157, pp. 572-576, (1987)

[5]

Robinson L., Grau P., Crandall B.F., Pregnancy outcomes after increasing maternal serum alpha-fetopro-tein levels, Obstct Gynecol, 74, pp. 17-20, (1989)

[6]

Johnson J.M., Harman C.R., Evans J.A., Macdonald K., Manning F.A., Maternal serum alpha-fetoprotein in twin pregnancy, Am J Obstet Gynecol, 162, pp. 1020-1025, (1990)

[7]

Johnson M.A., Palomaki G.E., Haddow J.E., Maternal serum alpha-fetoprotein levels among black and white women with open spina bifida: A US collaborative study, Am J Obstet Gynecol, 162, pp. 328-331, (1990)

[8]

Hunter A., Cox D.M., Counseling problems when twins are discovered at genetic amniocentesis, Clin Genet, 16, pp. 34-42, (1979)

[9]

Drugan A., Dvorin E., Koppitch F.C., Greb A., Krivchcnia E.L., Evans Ml: Counseling for low maternal serum alpha-fetoprotein should emphasize all chromosome anomalies, not just Down syndrome, Obslet Gynecol, 73, pp. 271-274, (1989)

[10]

Wald N.J., Cuckle H.S., Recent advances in screening for neural tube defects and Down's syndrome, Fetal Diagnosis of Genetic Defects. Baillieres Clin Obstct Gynaecol, 1, pp. 649-676, (1987)

← 1 2 →